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Obstructive sleep apnea and hipoapnea syndrome 
(OSAHS) is a disorder that affects about 4% of the adult 
population, and besides the social problems associated to 
snoring and extreme day time sleepiness, it is preoccupying 
since it may cause pulmonary hypertension and cardiac 
failure. Review and discussion - Through a literature review, 
we discuss the use of oral appliances to treat this condition, in 
regards of therapy effectiveness and limitations, main clinical 
symptoms, major occlusal side effects, rate of improvement 
and patient satisfaction. Conclusions - We concluded that 
the use of oral appliances should be a first choice treatment 
for mild to moderate OSAHS, being dental, joint and muscular 
discomforts, hypersalivation and xerostomia, the most 
frequent clinical symptoms, with light occlusal side effects 
that normally do not bother the patients, with a good degree 
of improvement and high satisfaction index.
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INTRODUCTION
Since 1985, Medicine and Dentistry have increased 
its focus on sleep respiratory disorders. Although there 
is a large number of disorders that may be included in 
this category, obstructive sleep apnea and the choices 
of its possible intra-oral treatments, have received more 
attention. 
Obstructive sleep apnea and hypopnea syndrome 
(OSAH) is defined by the apnea/hypopnea index  (AHI) 
per hour of at least five events per hour, added to clinical 
symptoms, being loud snoring and excessive daytime 
sleepiness, the most important ones.1,2
This syndrome affects as many as 4% of the adult 
population, being more predominant in men, increasing 
from the 5th life decade onwards3,4. Patients with OSAH 
have significantly more hypertension, ischemic heart di-
sease and brain vascular disease than individuals without 
the syndrome. Mortality related to obstructive sleep apnea 
has increased significantly, when the AHI > 20 events per 
hour5.
Some important anatomic features observed ra-
diographically in patients with OSAH include: narrow 
mandible arch; maxillary and mandibular retrognathism; 
increased lower facial height; lower and more anterior 
position of the hyoid bone; reduced pharyngeal area; in-
creased cranio-cervical angle; decreased distance between 
the base of the tongue and the posterior pharyngeal wall; 
hypertrophied tonsils and adenoids6-10, over-erupted ma-
xillary and mandibular dentition and enlarged tongue6,7.
OSAH treatment goal is to restore normal breathing 
during sleep, and therefore, ending excessive daytime sle-
epiness, neuropsychological and cardiovascular alterations; 
and at the same time it should offer the patient good quality 
of life, without offering side effects or risks11.
Treatment options for OSAH include sleep hygiene, 
that is to say, avoidance of alcohol and other drugs; ade-
quate body position and weight loss11, surgical procedures, 
such as partial glossectomy, uvulopalatopharyngoplasty, 
maxillary and mandibular advancement procedures, and 
also clinical treatments, such as nasal CPAP and intra-oral 
devices12.
The most commonly used clinical treatment includes 
the continuous positive air pressure procedure (CPAP) 
applied through a device that generates and directs a 
continuous air flow ( 40 to 60l/min.), through a flexible 
tube to a nasal mask tightly strapped to the patient’s face. 
3,11. According to Sullivan et al.5, although the treatment of 
obstructive sleep apnea with CPAP is highly effective, it is 
little tolerated by approximately 36% of patients, specially 
by those with medium severity.
There has been a recent increased interest on the 
principle of treatment with intra-oral devices, because 
they are a simple and non-invasive option, different de-
vices have been developed. 5. The devices approved by 
the Food and Drug Administration (FDA) are the tongue 
retainers and mandibular protruding devices, being the 
most widely used options2.
However, some questions need to be addressed in 
order to make this therapy into an efficient and safe alterna-
tive for treating such respiratory disorders. These questions 
are related to the correct indication regarding the severity 
of the condition5, that is to say, which degrees of apnea 
could be treated with this therapeutic option, patient’s 
comfort when using the intra-oral device13-15, user’s and 
room mate’s evaluation regarding the improvement of the 
clinical condition14 and side effects.
The goal of this paper is based on the review of 
recent literature, and to check the following:
1 - Mandibular protruding devices efficacy for tre-
ating obstructive sleep apnea.
2 - Main clinical symptoms informed by patients.
3 - Main occlusal side effects produced by mandi-
bular protruding devices.
4 - Patients’ collaboration level and satisfaction rate 
regarding the treatment.
DISCUSSION
Regarding the efficacy of intra-oral devices, several 
authors state in their studies16-19 that they represent a good 
alternative for treating snoring and OSAH, due to a redu-
ced cost and their relatively comfortable use, being more 
accepted by patients. Although there are conflicting doubts 
on the efficacy of intra-oral devices for treating snoring and 
OSAH, its use in the treatment of medium severity apnea 
has received great attention and acceptability. 8
A literature review done by Warunek (2004)10 
showed that since 1985, approximately 150 articles have 
been published describing different devices and its efficacy 
in treating OSAH.
The mechanics of mandibular protruding devices 
aims to increase upper airway volume2,  having as a result 
mandibular advancement, which places the tongue away 
from the posterior pharyngeal wall, lowering this bone and 
moving the tongue away from the soft palate20, altering 
the position of the hyoid bone and therefore, modifying 
the space of the hypopharyngeal airway. 3
Regarding its effectiveness, Walker-Engström et 
al. (2002)4 managed to get at least a 50% improvement 
in the apnea - hypopnea index (AHI) in 81% of patients, 
and normalization in 63% of patients who used intra-oral 
devices which promoted mandibular advancement of 50% 
of protrusion maximum capacity. Using polysomnography, 
Neill et al. (2002)14 evaluated the use of intra-oral devices 
of mandibular protrusion and concluded that it was a com-
plete success in 21.1% of patients,  partial success in 52.6% 
and a failure in 26.3%, with an average treatment period 
of 6.5 weeks. According to the study done by Fritsch et al. 
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(2001)13, a respiratory improvement was confirmed with 
the device, when all patients showed a persistent relief of 
symptoms, 12 to 30 weeks after its use.
In the study done by Pancer, Al-Faifi & Hoffstein 
(1999)20, they observed a significant reduction in all rates 
related to respiratory disorders and the subjective asses-
sment of room mates revealed a striking improvement in 
snoring (96% were evaluated as “ loud snoring” frequently 
before using the device and only 2% using the device). 
The objective analysis showed that of the 75 patients, 38 
were cured (normalization of AH index), 31 improved 
AH index without normalization, three were only snorers, 
and three had a worse AH index with the device. Accor-
ding to Katto et al. (2000)17, among the patients who had 
mandibular advancement of at least 6mm, there was an 
improvement of their condition with normalization in 65%. 
They also reported that patients who normalized their 
indexes were the less obese of the study and suggested 
that obese patients should not be suitable candidates to 
therapy with oral devices. In the study done by Ferguson 
et al. (1997)16, when compared to the non-adjustable man-
dibular repositioning device, the adjustable mandibular 
protruding device, was associated with a higher success 
of treatment (55% vs. 48%), and fewer failures (5% vs. 
24%). For Clark et al. (1993)21, the follow-up makes clear 
that when the protrusive position was lower than 75% of 
maximum protrusion reached by the patient (normally < 
5mm) the advancement therapy did not work, and they 
stated that for those patients who do not tolerate such a 
degree of advancement, this would not be the indicated 
therapy.
For Fransson et al. (2004)22, the treatment with 
mandibular protruding devices has several advantages 
and can be considered as first choice treatment for a large 
group of patients, including patients with severe OSAH, if 
an optimum advancement quantity could be used. In our 
sample, more than 80% of patients with OSAH normalized 
their values of oxygen saturation (with an improvement of 
50% or more), and 90% reported a subjective reduction of 
snoring and apnea (50% reduction or more).
Regarding clinical symptoms, dental or mouth dis-
comfort were the most frequently symptoms reported by 
patients in all samples. In the work done by Neill et al. 
(2002)14, 26% of patients experienced some pain in the 
mouth and 42% reported sore teeth and gums. Pancer, Al-
Faifi & Hoffstein (1999)20 reported dental discomfort some 
times or with frequency in more than 32% of patients. 
According to Clark, Sohn & Hong (2000)3, 38% of patients 
reported suffering from   toothache. For O’Sullivan (1995)5, 
the main effect reported was medium discomfort in the 
dental arcs when waking up, with reduction of the symp-
tom in three weeks, in most cases. Besides discomfort, joint 
and masticatory musculature pain was also reported, found 
in different levels in the works by 2,4,8,9,12,22. Other frequent 
clinical symptoms were excessive salivation8,13 due to the 
new tongue position and to the presence of the device 
inside the mouth2,3,8,9,12,13,14,20, and xerostomia3,5. Fransson 
et al. (2004)22 and Bondemark & Lindman (2000)9 also 
reported the frequency reduction in headache in patients 
of their samples.
Among the frequently observed occlusal alterations, 
there are overjet, overbite reduction, lower incisive proclin
ation9,10,13,18,21,22, and the establishment of lateral open bite. 
22 According to Fransson et al. (2002)23, a small overjet 
is a limiting factor to be considered in the treatment with 
this type of device.
According to Robertson (2001)24, the main changes 
observed are due to the vertical repositioning of the man-
dibular condyle in the glenoid cavity. These alterations 
may become visible within 6 months. Dental changes start 
happening later on, and they will be significant at the 30 
month follow-up. Bondemark & Lindman (2000)9 carried 
out a two year follow-up work and they observed a sig-
nificant decrease in overjet and overbite, and significant 
changes in molar relation, indicating a more mesial sagittal 
relation and/or changes in the incisive inclination.
Some authors25-27 correlate the observed occlusal 
changes with the type of initial occlusion in patients 
using mandibular protruding devices for OSAH treatment. 
Almeida et al. (2006)25 and Almeida et al. (2006)26 carried 
out some long term assessment works, 4.7 years average. 
Five orthodontists made a visual comparison of the den-
tal arcades plaster molds of 70 patients, and 71 patients 
had their cephalometric x-rays analyzed. In the analysis 
of the models, the authors verified that changes occur in 
85.7% of cases, being favorable or unfavorable depending 
on the initial mal-occlusion. On the other hand, on the 
cephalometric assessment, they observed a decrease of 
overjet and overbite, changes in the incisive and molar 
teeth position and consequent alteration in the mandibular 
position, also varying depending on the initial occlusion. 
Marklund (2006)27 confirmed this correlation between 
the observed changes and initial occlusion on their work 
with 187 patients, during an average follow-up period of 
5.4 years.
The assessment of the patient compliance should 
be done in order to be able to indicate the treatment with 
mandibular protruding device in an effective manner, since 
this appears to be the main difficulty for treatment with 
CPAP. Compliance depends on the comfort level obtained 
by patient during the use of the devices and their own as-
sessment regarding the result of the therapy. All the studies 
show a high level of compliance in using the device, and 
always in a higher level than the use of CPAP when they 
are compared2-5,14,16,20,22. According to Almeida (2002)2 and 
Ferguson et al. (1997)16 patients have a significant prefe-
rence for the use of mandibular protruding devices rather 
than the use of CPAP, even those for whom CPAP efficacy 
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was better than intra-oral devices. Walker-Engströn et al. 
(2002)4 found a compliance level of 82% after one year 
and 62% after four years. Fransson et al. (2004)22 found 
an 84% compliance rate on the two year follow-up. Clark, 
Sohn & Hong (2000)3 reported that with the long term use 
(three or more years), compliance was higher than 51%, 
whereas Pancer, Al-Faifi & Hoffstein (1999)20 stated that 350 
days after device fitting, 86% of patients still were using it. 
According to Neill et al. (2002)14 the device was used by 
53% of patients every night, by 26% more than three night 
a week, by 21% less than that. A high satisfaction rate was 
reported by articles assessing this item. 4,9,20.
CONCLUSIONS
From the bibliography review focused on answering 
the main doubts on the use of intra-oral devices for treating 
OSAH, we can conclude the following:
1-        Intra-oral devices for mandibular advan-
cement can be considered as first choice treatment for 
patients with medium to moderate OSAH, because the 
devices show a significant condition improvement and 
a greater acceptability from patients when compared to 
CPAP. These types of devices can be tried in patients 
with severe OSAH when they are intolerant to treatment 
with CPAP.
2-        The main clinical symptoms informed 
by patients are dental, joint and muscular discomfort, 
hyper salivation and xerostomia, reduction in headache 
frequency and improvement of snoring (frequency and 
intensity).
3-        The main occlusal side effects found were 
overjet reduction, overbite reduction, lower incisive procli-
nation, establishment of lateral open bite. However, most 
of the time without causing great discomfort to patients.
4-             Treatment with mandibular protruding 
devices show a higher compliance level than
 CPAP, even in patients who had a higher efficacy 
with CPAP than with intra-oral devices. 
Regarding patient’s satisfaction with treatment, it 
was observed a high rate in all the studies 
that included this item in their assessments. 
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